President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

On the surface, the president appears to be working on lowering the costs of medications. Just below the surface, his efforts ...

Analysts say the departure of the CBER head may alleviate overhang in the cell and gene therapy space. Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and ...

The recent move to introduce an “Amazon-style” prescription tracking in the NHS App is a crucial first step. People want ...

The American Medical Association expresses "deep concern" over a report that Health and Human Services Secretary Robert F.

President Donald Trump called out 17 Big Pharma CEOs over "exorbitant" drug pricing in individual letters sent out Thursday, ...

Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.

Eramol, a UK-based pharmaceutical contract development and manufacturing organisation (CDMO), is pleased to announce ...